Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (171-180 of 279) with videos related to

Pageof 28
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2019
A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trialsChengjie Xiong, Jingqin Luo, Folasade Agboola, et al.
Journal of Alzheimer'S Disease : JAD|February 3, 2016
Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot StudyPratishtha Chatterjee, Wei L F Lim, Guanghou Shui, et al.
Neuroimage|April 22, 2022
Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer diseasePeter R Millar, Patrick H Luckett, Brian A Gordon, et al.
Acta Neuropathologica|November 30, 2018
Current state of Alzheimer's fluid biomarkersJosé Luis Molinuevo, Scott Ayton, Richard Batrla, et al.
Annals of Neurology|July 18, 2018
Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Alison Goate, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 9, 2022
Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer DiseaseQing Wang, Gengsheng Chen, Suzanne E Schindler, et al.
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Plos One|January 26, 2011
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseaseRichard J Perrin, Rebecca Craig-Schapiro, James P Malone, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Pageof 28

Showing results (171-180 of 279) with videos related to

Sort By:
Pageof 28
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2019
A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trialsChengjie Xiong, Jingqin Luo, Folasade Agboola, et al.
Journal of Alzheimer'S Disease : JAD|February 3, 2016
Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot StudyPratishtha Chatterjee, Wei L F Lim, Guanghou Shui, et al.
Neuroimage|April 22, 2022
Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer diseasePeter R Millar, Patrick H Luckett, Brian A Gordon, et al.
Acta Neuropathologica|November 30, 2018
Current state of Alzheimer's fluid biomarkersJosé Luis Molinuevo, Scott Ayton, Richard Batrla, et al.
Annals of Neurology|July 18, 2018
Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Alison Goate, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 9, 2022
Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer DiseaseQing Wang, Gengsheng Chen, Suzanne E Schindler, et al.
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Plos One|January 26, 2011
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseaseRichard J Perrin, Rebecca Craig-Schapiro, James P Malone, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Pageof 28